Legend Biotech Corp - Ordinary Shares (LEGN)

CUSIP: 52490G102

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Ordinary Shares
Shares outstanding
368,659,889
Total 13F shares
91,534,759
Share change
+5,093,246
Total reported value
$4,053,943,715
Put/Call ratio
103%
Price per share
$44.29
Number of holders
173
Value change
+$152,693,975
Number of buys
105
Number of sells
84

Security key

52490G102

Report period

Q2 2024

Institutions

173

Top holders

10

Top shareholders of LEGN - Legend Biotech Corp - Ordinary Shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
4.4%
16,147,032
$905,687,025 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
3%
10,949,120
$614,137,000 31 Mar 2024
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
1.9%
6,861,097
$384,838,931 31 Mar 2024
13F
HHLR ADVISORS, LTD.
13F
Company
1.6%
5,984,550
$335,673,410 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
1.5%
5,384,030
$301,990,242 31 Mar 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.71%
2,614,423
$146,642,986 31 Mar 2024
13F
Capital World Investors
13F
Company
0.65%
2,385,960
$133,828,496 31 Mar 2024
13F
WESTFIELD CAPITAL MANAGEMENT CO LP
13F
Company
0.61%
2,239,774
$125,628,902 31 Mar 2024
13F
Capital International Investors
13F
Company
0.59%
2,181,074
$122,336,441 31 Mar 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.55%
2,014,012
$112,982,038 31 Mar 2024
13F
Paradigm Biocapital Advisors LP
13F
Company
0.54%
1,982,006
$111,170,717 31 Mar 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.51%
1,890,796
$106,054,748 31 Mar 2024
13F
FEDERATED HERMES, INC.
13F
Company
0.42%
1,537,060
$86,213,695 31 Mar 2024
13F
BRAIDWELL LP
13F
Company
0.34%
1,243,795
$69,764,462 31 Mar 2024
13F
TimesSquare Capital Management, LLC
13F
Company
0.31%
1,158,500
$64,980,000 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.31%
1,144,476
$64,193,659 31 Mar 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.3%
1,113,158
$62,437,032 31 Mar 2024
13F
STATE STREET CORP
13F
Company
0.28%
1,048,002
$58,782,432 31 Mar 2024
13F
ArrowMark Colorado Holdings LLC
13F
Company
0.28%
1,046,739
$58,711,591 31 Mar 2024
13F
JOHNSON & JOHNSON
13F
Company
0.22%
814,586
$45,690,129 31 Mar 2024
13F
Holocene Advisors, LP
13F
Company
0.21%
761,626
$42,719,602 31 Mar 2024
13F
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC
13F
Company
0.2%
751,935
$42,176,034 31 Mar 2024
13F
PFM Health Sciences, LP
13F
Company
0.2%
734,293
$41,186,494 31 Mar 2024
13F
Avidity Partners Management LP
13F
Company
0.18%
668,300
$37,484,947 31 Mar 2024
13F
Altitude Crest Partners Inc.
13F
Company
0.18%
652,732
$36,611,738 31 Mar 2024
13F
Boxer Capital, LLC
13F
Company
0.16%
600,000
$33,654,000 31 Mar 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.15%
552,413
$30,984,845 31 Mar 2024
13F
Rock Springs Capital Management LP
13F
Company
0.14%
499,486
$28,016,170 31 Mar 2024
13F
Artisan Partners Limited Partnership
13F
Company
0.13%
492,099
$27,601,833 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.13%
462,607
$25,815,573 31 Mar 2024
13F
Capital International, Inc./CA/
13F
Company
0.12%
453,664
$25,446,014 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.11%
409,553
$22,971,827 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.11%
397,199
$22,278,892 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.1%
371,091
$20,814,494 31 Mar 2024
13F
FRANKLIN RESOURCES INC
13F
Company
0.1%
366,388
$20,550,703 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.09%
342,033
$19,184,634 31 Mar 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.09%
330,323
$18,527,819 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.08%
310,408
$17,410,785 31 Mar 2024
13F
Legal & General Group Plc
13F
Company
0.08%
307,335
$17,238,419 31 Mar 2024
13F
Bellevue Group AG
13F
Company
0.08%
293,270
$16,449,514 31 Mar 2024
13F
Tri Locum Partners LP
13F
Company
0.08%
283,773
$15,916,828 31 Mar 2024
13F
BAMCO INC /NY/
13F
Company
0.08%
276,827
$15,527,226 31 Mar 2024
13F
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC
13F
Company
0.06%
235,493
$13,208,802 31 Mar 2024
13F
First Turn Management, LLC
13F
Company
0.06%
228,251
$12,802,599 31 Mar 2024
13F
S.c.a. Candriam
13F
Individual
0.06%
221,032
$12,397,685 31 Mar 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.06%
211,650
$11,871,449 31 Mar 2024
13F
Bridgewater Associates, LP
13F
Company
0.06%
208,900
$11,717,201 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.06%
206,507
$11,582,978 31 Mar 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.05%
186,392
$10,454,727 31 Mar 2024
13F
Russell Investments Group, Ltd.
13F
Company
0.05%
183,741
$10,306,068 31 Mar 2024
13F

Institutional Holders of Legend Biotech Corp - Ordinary Shares (LEGN) as of Q2 2024

As of 30 Jun 2024, Legend Biotech Corp - Ordinary Shares (LEGN) was held by 173 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 91,534,759 shares. The largest 10 holders included FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, RA CAPITAL MANAGEMENT, L.P., HHLR ADVISORS, LTD., BlackRock Inc., WESTFIELD CAPITAL MANAGEMENT CO LP, WELLINGTON MANAGEMENT GROUP LLP, JANUS HENDERSON GROUP PLC, Capital International Investors, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/. This page lists 174 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
187
Q2 2024 holders
173
Holder diff
-14
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .